Previous studies have linked negative PD-L1 expression with superior overall survival (OS) in NSCLC patients compared to patients with positive PD-L1 expression [20, 39, 40], while others concluded that PD-L1 expression had no significant correlation with OS but is related to longer relapse-free survival [41]. Here, CD274 is linked to non-small cell lung carcinoma.